ESPR Esperion Therapeutics Inc

USD 2.11 -0.10 ( -4.52)%
Icon

Esperion Therapeutics Inc (ESPR) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.11

-0.10 (-4.52)%

USD 0.40B

0.01B

USD 8.13(+285.07%)

N/A

Icon

ESPR

Esperion Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 2.11
-0.10 ( -4.52)%

Esperion Therapeutics Inc (ESPR) Stock Forecast

USD 8.13
(+285.07%)

Based on the Esperion Therapeutics Inc stock forecast from 3 analysts, the average analyst target price for Esperion Therapeutics Inc is USD 8.13 over the next 12 months. Esperion Therapeutics Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Esperion Therapeutics Inc is Very Bearish, which is based on 0 positive signals and 6 negative signals. At the last closing, Esperion Therapeutics Inc’s stock price was USD 2.11. Esperion Therapeutics Inc’s stock price has changed by +3.43% over the past week, +3.43% over the past month and +104.85% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...